Cellectar Biosciences - Stock Price History | CLRB

Historical daily share price chart and data for Cellectar Biosciences since 2020 adjusted for splits. The latest closing stock price for Cellectar Biosciences as of June 03, 2020 is 1.03.
  • The all-time high Cellectar Biosciences stock closing price was 1040000.00 on November 30, 2005.
  • The Cellectar Biosciences 52-week high stock price is 3.33, which is 223.3% above the current share price.
  • The Cellectar Biosciences 52-week low stock price is 1.01, which is 1.9% below the current share price.
  • The average Cellectar Biosciences stock price for the last 52 weeks is 1.95.
Cellectar Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.0526 1.5800 2.8500 1.0600 2.2500 45.16%
2018 7.0838 13.7000 13.7000 1.2900 1.5500 -88.69%
2017 17.2692 12.8000 26.6000 11.2000 13.7000 12.30%
2016 31.0365 73.2000 76.1500 10.5000 12.2000 -83.40%
2015 250.6595 306.0100 355.0000 68.5000 73.5000 -76.21%
2014 552.5469 760.0000 840.0000 198.9500 309.0000 -58.24%
2013 910.9524 1480.0000 1580.0000 600.0000 740.0000 -50.00%
2012 1921.5200 900.0000 4000.0000 860.0000 1480.0000 68.18%
2011 4329.3590 12307.6923 15384.6154 740.0000 880.0000 -90.47%
2010 114261.2943 913846.1538 913846.1538 6153.8462 9230.7692 -98.82%
2009 217191.6972 144615.3846 781538.4615 104615.3846 781538.4615 440.43%
2008 159464.8829 187692.3077 246153.8462 67692.3077 144615.3846 -21.67%
2007 262298.4983 276923.0769 418461.5385 132307.6923 184615.3846 -31.82%
2006 376647.2571 584615.3846 695384.6154 193846.1538 270769.2308 -56.44%
2005 775736.2637 840000.0000 1040000.0000 498461.5385 621538.4615 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.012B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.830B 28.41
Medtronic (MDT) Ireland $130.331B 21.19
Stryker (SYK) United States $74.362B 24.14
Boston Scientific (BSX) United States $52.532B 24.70
Baxter (BAX) United States $46.146B 28.17
Lonza Group Ag (LZAGY) Switzerland $36.460B 0.00
Terumo (TRUMY) Japan $30.335B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.429B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.519B 16.69
ResMed (RMD) United States $23.112B 36.47
Smith & Nephew SNATS (SNN) United Kingdom $18.370B 0.00
Sunny Optical Technology (SNPTF) China $15.252B 0.00
Bio-Rad Laboratories (BIO) United States $14.618B 66.54
Insulet (PODD) United States $11.765B 1165.63
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $8.366B 0.00
Perrigo (PRGO) Ireland $7.685B 13.75
Quidel (QDEL) United States $7.081B 55.64
Hill-Rom Holdings (HRC) United States $6.783B 19.12
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Canopy Growth (CGC) Canada $5.662B 0.00
Haemonetics (HAE) United States $5.428B 32.60
ICU Medical (ICUI) United States $4.102B 29.92
GW Pharmaceuticals (GWPH) United Kingdom $3.935B 0.00
Neogen (NEOG) United States $3.757B 63.63
Agios Pharmaceuticals (AGIO) United States $3.602B 0.00
Envista Holdings (NVST) United States $3.430B 0.00
NuVasive (NUVA) United States $3.226B 25.90
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.985B 0.00
National Vision Holdings (EYE) United States $2.196B 37.99
TG Therapeutics (TGTX) United States $2.063B 0.00
AtriCure (ATRC) United States $1.801B 0.00
Aurora Cannabis (ACB) Canada $1.478B 0.00
Cardiovascular Systems (CSII) United States $1.341B 0.00
Aphria (APHA) Canada $1.203B 0.00
NanoString Technologies (NSTG) United States $1.183B 0.00
MacroGenics (MGNX) United States $1.079B 0.00
Cerus (CERS) United States $1.051B 0.00
Phibro Animal Health (PAHC) United States $1.038B 20.70
InMode (INMD) Israel $0.992B 20.97
PetIQ (PETQ) United States $0.847B 24.46
Omeros (OMER) United States $0.813B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.768B 130.08
Quanterix (QTRX) United States $0.762B 0.00
OraSure Technologies (OSUR) United States $0.752B 151.38
VAREX IMAGING (VREX) United States $0.749B 18.59
Eagle Pharmaceuticals (EGRX) United States $0.718B 51.43
Zynex (ZYXI) United States $0.650B 65.23
Meridian Bioscience (VIVO) United States $0.645B 24.27
Lantheus Holdings (LNTH) United States $0.560B 11.26
Vapotherm (VAPO) United States $0.556B 0.00
LeMaitre Vascular (LMAT) United States $0.535B 30.49
Surmodics (SRDX) United States $0.517B 62.31
Owens & Minor (OMI) United States $0.481B 12.73
Repro-Med Systems (KRMD) United States $0.425B 357.00
BioLife Solutions (BLFS) United States $0.417B 146.00
Cytosorbents (CTSO) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.373B 27.09
Viemed Healthcare (VMD) United States $0.324B 29.03
Organigram Holdings (OGI) Canada $0.316B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.285B 0.00
HEXO (HEXO) $0.267B 0.00
Female Health (VERU) United States $0.237B 0.00
InfuSystems Holdings (INFU) United States $0.236B 130.78
Chimerix (CMRX) United States $0.204B 0.00
Evolus (EOLS) United States $0.161B 0.00
Fonar (FONR) United States $0.158B 13.98
Chembio Diagnostics (CEMI) United States $0.155B 0.00
Bovie Medical (APYX) United States $0.150B 0.00
Rockwell Medical (RMTI) United States $0.146B 0.00
Exagen (XGN) United States $0.142B 0.00
Surface Oncology (SURF) United States $0.140B 0.00
United Health Products (UEEC) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) Canada $0.135B 0.00
MTech Acquisition (KERN) United States $0.124B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.108B 0.00
United-Guardian (UG) United States $0.080B 18.62
Brainsway (BWAY) Israel $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.044B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
NF Energy Saving (BIMI) China $0.028B 0.00
FSD PHARMA INC (HUGE) Canada $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.014B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00